Edition:
United States

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

4.11USD
15 Dec 2017
Change (% chg)

$-0.04 (-0.96%)
Prev Close
$4.15
Open
$4.24
Day's High
$4.24
Day's Low
$4.11
Volume
1,008
Avg. Vol
3,293
52-wk High
$15.12
52-wk Low
$3.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
FY 2015 Dec '15 0.00 -4.390
Sep '15 0.00 -4.733
Jun '15 0.00 -3.595
Mar '15 0.00 -5.331
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. -- 40.75 45.35
P/E Low - Last 5 Yrs. -- 23.60 24.23
Beta -- 0.92 0.91
Price to Sales (TTM) -- 3.92 5.95
Price to Book (MRQ) 1.38 4.85 5.68
Price to Tangible Book (MRQ) 1.55 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 53.23 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 5.15 5.62
Sales - 5 Yr. Growth Rate -- 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 88.39 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago 78.09 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate -- 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 9.12 3.50 3.56
LT Debt to Equity (MRQ) 0.46 11.01 13.38
Total Debt to Equity (MRQ) 0.46 17.15 19.38
Interest Coverage (TTM) -- 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.50 15.63
Operating Margin (TTM) -- 14.76 6.56
Operating Margin - 5 Yr. Avg. -- 14.33 11.00
Pre-Tax Margin (TTM) -- 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -- 14.64 11.41
Net Profit Margin (TTM) -- 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -- 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 945,342,213 851,801,741
Net Income/Employee (TTM) -1,842,875 110,573,246 99,542,701
Receivable Turnover (TTM) -- 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.56
Asset Turnover (TTM) 0.00 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -49.36 11.86 11.31
Return on Assets - 5 Yr. Avg. -- 12.86 12.28
Return on Investment (TTM) -57.71 15.06 14.43
Return on Investment - 5 Yr. Avg. -- 16.81 16.07
Return on Equity (TTM) -57.96 16.55 16.01
Return on Equity - 5 Yr. Avg. -- 17.82 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 16.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.23%
# of Holders: 29
Total Shares Held: 3,771,647
3 Mo. Net Change: 127,759
# New Positions: 3
# Closed Positions: 8
# Increased Positions: 8
# Reduced Positions: 12
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.